4551.T stock at JPY 6,350 intraday 17 Feb 2026: oversold bounce offers short-term trade setup

The 4551.T stock trades at JPY 6,350.00 intraday on 17 Feb 2026, setting up a classic oversold bounce opportunity after a sharp pullback into support. Volume is 48,100.00 versus an average 49,218.00, keeping liquidity intact for short-term moves. Key fundamentals — EPS 192.43, PE 33.00, and a book value per share JPY 4,356.91 — support selective buying for traders focused on a measured rebound rather than a long-term reposition.

Intraday price action for 4551.T stock

Torii Pharmaceutical (4551.T) opened at JPY 6,340.00 and is trading between the day low JPY 6,330.00 and high JPY 6,350.00. The tight range and near-average volume (48,100.00) signal order flow that favors a short-term mean reversion trade.

The Keltner channel mid sits at JPY 6,350.00 with a lower band at JPY 6,310.00, giving a clear technical floor for an oversold bounce attempt.

Fundamentals and valuation context for 4551.T stock

Fundamentals remain resilient: market cap JPY 178,531,513,650.00, cash per share JPY 1,203.19, and a strong current ratio 5.18. Price-to-book is 1.46 and price-to-sales is 2.81, below some peers in the Healthcare sector.

Profitability shows operating margin 10.72% and net margin 8.52%, which provide support if market sentiment stabilizes. These metrics temper downside risk on a short-term bounce.

Technical setup and oversold bounce strategy for 4551.T stock

Short-term technicals show an ATR of 20.00, and the stock is testing the Keltner lower band JPY 6,310.00, a common entry for oversold bounces. Traders can size positions with tight stops below JPY 6,300.00 to limit downside.

A conservative intraday target is JPY 6,600.00 and a stretch target JPY 7,000.00 if momentum confirms. Use volume confirmation above 60,000.00 to validate breakout continuation.

Meyka AI rates 4551.T with a score out of 100

Meyka AI rates 4551.T with a score out of 100: 72.64 (Grade B+, suggestion: BUY). This grade factors in S&P 500 benchmark comparison, sector performance, financial growth, key metrics, and analyst consensus.

This internal grade is informational only and not investment advice. Traders using an oversold bounce approach should weigh the grade alongside intraday technical confirmations.

Forecasts, price targets and risk-reward view for 4551.T stock

Meyka AI’s forecast model projects a 1‑year level of JPY 5,526.11, a 3‑year level of JPY 6,581.12, and a 5‑year level of JPY 7,634.08. Versus the current JPY 6,350.00, the model implies a near-term downside to the 1‑year figure of -12.97% and a 5‑year upside of +20.16%.

Forecasts are model-based projections and not guarantees. For intraday oversold bounce trades, pair short-term targets (JPY 6,600.00, JPY 7,000.00) with strict stops and monitor sector momentum in Healthcare.

Catalysts, sector context and watch points for 4551.T stock

Watch for corporate updates, Japan Pharmaceutical approvals, and partner distribution news from Torii that could shift sentiment. Healthcare sector YTD performance is modest; sector PE averages 23.14, making Torii’s PE 33.00 slightly premium but supported by stable margins.

Immediate risk factors include slower drug uptake, receivables cycle (days sales outstanding 159.93) and inventory turnover (2.19). Manage position size around these operational exposures.

Final Thoughts

Key takeaways for the 4551.T stock intraday oversold bounce: price at JPY 6,350.00 sits close to the Keltner lower band JPY 6,310.00, offering a defined entry for short-term traders. Meyka AI’s forecast model projects JPY 5,526.11 (1 year) and JPY 7,634.08 (5 years), implying a near-term downside of -12.97% and a longer-term upside of +20.16% versus the current price. Our short-term price targets for an oversold bounce are JPY 6,600.00 (first target) and JPY 7,000.00 (secondary target), with a stop below JPY 6,300.00. Remember that Meyka AI is an AI-powered market analysis platform and forecasts are model-based projections and not guarantees. Traders should confirm entries with rising volume and sector stability before adding exposure.

FAQs

Disclaimer:

Stock markets involve risks. This content is for informational purposes only. Past performance does not guarantee future results. Meyka AI PTY LTD provides market analysis and data insights, not financial advice. Always conduct your own research and consider consulting a licensed financial advisor.